ProQR Therapeutics shares are trading higher after Evercore ISI Group maintained its Outperform rating on the stock and raised its price tar
ProQR Therapeutics shares are trading higher after Evercore ISI Group maintained its Outperform rating on the stock and raised its price target from $5 to $6.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.